PathAI uses machine learning to automate pathology, enabling labs, biopharma and clinicians to analyze biopsy images quickly and accurately.

Introduction

PathAI is working towards better patient outcomes through AI applied to pathology. Its leading solution, AISight, establishes a cloud‑native hub for whole‑slide image management, case workflows and third‑party AI modules. The platform is extensively used by biopharma organizations and pathology labs globally with more than 450 pathologist contributors and 15M+ annotated images. It accommodates research use as well as CE‑IVD regulatory procedures in Europe.

Freemium Model

Enterprise‑Grade

AI‑Powered

Workflow Efficiency

Review

PathAI uses machine learning to automate pathology, enabling labs, biopharma and clinicians to analyze biopsy images quickly and accurately. Its flagship platform, AISight, provides a single, centralized digital pathology workflow with built-in AI capabilities. PathAI is used for research and clinical applications like biomarker measurement, tumor identification and fibrosis quantification. The platform is relied upon by leading pharma companies and pathology labs. Its biggest advantage is enterprise-class performance, varied AI algorithms, and cloud-native team-based workflows. The biggest disadvantage is the requirement for institutional integration and maybe high initial costs.

Features

AISight Image Management

Cloud‑native platform for case assignment, viewing of slides, AI‑based overlays, and algorithm integration.

PathExplore Panel

Quantitative AI tool analyzing tumor microenvironment at single‑cell resolution with >600 features that are interpretable.

Broad Algorithm Library

Software for detection of tumors, biomarker scoring (PD‑L1, HER2), fibrosis/collagen quantitation, quality assurance, and triage.

Third‑Party Integration

Compliant with external AI software (Paige, Visiopharm, etc.) through AISight Link API.

Regulatory Compliance

Research‑use in US, CE‑IVD in EU/UK for diagnostic support.

Collaboration & Scalability

Suitable for remote review, cross‑institution collaboration, and scalable deployment—recent deal with Northwestern Medicine evidences live clinical deployment.

Best Suited for

Biopharma & Clinical Trials

AI-driven biomarker discovery, trial quality management, and therapeutic development collaborations.

Pathology Laboratories

Digital pathology workflows with AI-powered triage and analysis, adopted by enterprise labs.

Academic & Research Institutions

Quantitative tumor microenvironment profiling and translational research.

Diagnostic Companies

Establishing standardized AI pipelines (PD-L1, cancer detection, fibrosis measures).

Strengths

Business‑scale cloud image management with AI overlays and LIS integration.

Robust algorithm library covering primary pathology endpoints.

Compliance with regulations (CE‑IVD) in international markets.

Strong adoption: 90% of top 15 biopharma organizations and several lab alliances.

Weakness

IT resources and training required for enterprise integration.

No transparent standard pricing; requires demo and negotiation.

Getting started with: step by step guide

Getting started with PathAI is easy:

Step 1: Request a demo

Go to PathAI website and arrange a demo for AISight and algorithm features.

Begin with research-use case or choose algorithm (e.g. tumor detection, biomarker panel) and add AISight to your lab’s image workflow.

For biopharma or clinical labs, co‑develop disease‑specific AI tools with PathAI experts (such as Northwestern Medicine collaboration).

Scale up to entire lab workflows, include modules such as PathExplore for TME analysis, and combine third‑party AI tools.

Enable CE‑IVD modules for use in diagnostics in compliant geographies; pursue guidance from the regulator for other geographies.

Frequently Asked Questions

Q: What is PathAI?

A: A provider of enterprise digital pathology platform (AISight) and AI algorithms for research and diagnostic workflows.

A: Yes, through bespoke enterprise deployment; CE‑IVD modules available in EU/UK, research‑use in US.

A: Request a demo via PathAI website, begin with a pilot integration of AISight and algorithms of interest.

Pricing

PathAI pricing is negotiated to order depending on lab size, volume of use, and desired depth of AI modules. Standard charges include annual licensing, cloud infrastructure charges, and algorithm development optionally. Get specific quotes from sales via PathAI website.

Alternatives

Paige

Provides AI diagnostics and pathology software with FDA‑cleared algorithms.

Visiopharm

Offers image analysis software for digital pathology and pharma research workflows.

Aperio eSlide Manager + QuPath

Open-source model uniting WSI management with community‑developed tools for analysis.

Share it on social media:

Leave feedback about this

  • Quality
  • Price
  • Service

Questions and answers of the customers

There are no questions yet. Be the first to ask a question about this product.

Send me a notification for each new answer.
AI Tools Marketplace
PathAI
PathAI uses machine learning to automate pathology, enabling labs, biopharma and clinicians to analyze biopsy images quickly and accurately.